Recently IXC (invex) on the asx had a phase 3 trial from their drug and failed to have success. It fell from 40-50cents to 20 cents… the difference between us and them is huge though. We literally already have distribution deals. No need to dilute anymore. Money coming in to fund phase 3, and if successful a LOT of money coming in… I think this has a great chance of succeeding imo
DXB Chart, page-376
-
- There are more pages in this discussion • 776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.005(1.02%) |
Mkt cap ! $264.1M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 46.5¢ | $2.410M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94600 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 16292 | 3 |
View Market Depth
| Last trade - 15.12pm 15/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |